Treating the Most Vulnerable and Costly in Diabetes

David V. Wagner, Maggie Stoeckel, Megan E. Tudor, Michael A. Harris

Research output: Contribution to journalReview articlepeer-review

25 Scopus citations


Diabetic ketoacidosis (DKA) is associated with negative health outcomes and high costs for patients, families, and communities. Interventions developed to effectively reduce DKA and related costs should target the multiple risk factors associated with DKA and adherence difficulties. Certain demographic, psychological, and family factors are associated with increased risk for adherence problems and DKA. Individuals with a combination of risk factors (e.g., mental health problems, low socioeconomic status, high family conflict) may be particularly vulnerable to DKA. Although several different interventions have demonstrated promise in improving adherence and/or decreasing the risk of DKA, the generalizability of treatment results to those individuals most vulnerable to DKA is limited. Approaches which include multiple evidence-based components of care, are flexible in treatment delivery (e.g., home- and community-based, utilize technology), and target the multiple risk factors across relevant systems (e.g., individual, family, school, medical) are warranted to effectively reduce DKA in vulnerable populations.

Original languageEnglish (US)
JournalCurrent diabetes reports
Issue number6
StatePublished - Apr 16 2015


  • Cost
  • DKA
  • Risk factor
  • Treatment
  • Type 1 diabetes
  • Vulnerable

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism


Dive into the research topics of 'Treating the Most Vulnerable and Costly in Diabetes'. Together they form a unique fingerprint.

Cite this